Overview of a Phase Ib study of venetoclax and obinutuzumab in CLL
Current and future CLL diagnostic tools
What are the economics of treating CLL?
Selinexor for CLL - mechanism of action and combination with ibrutinib
Current research at Weill Cornell and the New York Genome Center